Roivant Sciences (ROIV) Short-Term Debt issuances (2020 - 2022)

Roivant Sciences has reported Short-Term Debt issuances for 3 years, with the latest figure at $159.9 million in Q4 2022.

• For the quarter ending Q4 2022, Short-Term Debt issuances rose 339.28% year-over-year to $159.9 million; the trailing twelve-month figure through Dec 2023 stood at $159.9 million (down 55.11% YoY), and the FY2023 full-year result was $159.9 million, up 339.28% from the prior year.
• Short-Term Debt issuances for Q4 2022 stood at $159.9 million, roughly flat from $159.9 million in the prior quarter.
• The five-year high for Short-Term Debt issuances was $159.9 million in Q2 2022, with the low at -$36.4 million in Q4 2020.
• Historically, Short-Term Debt issuances has averaged $71.2 million across 3 years, with a median of $36.4 million in 2021.
• Annual changes were most pronounced in 2021 — Short-Term Debt issuances surged 200.0% — and 2022, when it soared 339.28%.
• Roivant Sciences' Short-Term Debt issuances stood at -$36.4 million in 2020, then surged by 200.0% to $36.4 million in 2021, then surged by 339.28% to $159.9 million in 2022.
• The last three Short-Term Debt issuances figures came in at $159.9 million (Q4 2022), $159.9 million (Q2 2022), and $36.4 million (Q4 2021), per Business Quant data.